|
|
|
Volumn 29, Issue 5, 2009, Pages
|
|
The article by Fintak et al on the incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
RANIBIZUMAB;
VASCULOTROPIN A;
ALPHA HEMOLYTIC STREPTOCOCCUS;
BACTERIAL EYE INFECTION;
DRUG ANTAGONISM;
ENDOPHTHALMITIS;
HUMAN;
INCIDENCE;
INJECTION;
ISOLATION AND PURIFICATION;
MICROBIOLOGY;
NOTE;
STAPHYLOCOCCUS EPIDERMIDIS;
STAPHYLOCOCCUS INFECTION;
STREPTOCOCCUS INFECTION;
STREPTOCOCCUS MITIS;
VITREOUS BODY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ENDOPHTHALMITIS;
EYE INFECTIONS, BACTERIAL;
HUMANS;
INCIDENCE;
INJECTIONS;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS EPIDERMIDIS;
STREPTOCOCCAL INFECTIONS;
STREPTOCOCCUS MITIS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VIRIDANS STREPTOCOCCI;
VITREOUS BODY;
|
|
EID: 66349084179
PISSN: None
EISSN: 15392864
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
